Table 1 Demographics, clinical and surgical data, oncological treatment, and outcomes for women 18–40 years old diagnosed with epithelial ovarian cancer in Sweden 2008–2015
Treated with FSS | Treated with RS | P-value | |
|---|---|---|---|
N (%) | 36 (43) | 47 (57) | |
Mean age, years (range) | 29 (19–39) | 37 (26–40) | < 0.001 |
Previous parity, n (%) | < 0.001 | ||
0 | 27 (75) | 16 (34) | |
1 | 6 (17) | 7 (15) | |
2 | 2 (6) | 17 (36) | |
≥3 | 0 | 4 (9) | |
FIGO stage, n (%) | 0.002 | ||
IA | 27 (75) | 18 (38) | |
IB | – | – | |
IC | 9 (25) | 29 (62) | |
IC1 | 6 | 19 | |
IC2 | 3 | 6 | |
IC3 | 0 | 2 | |
IC unspecified | 0 | 2 | |
Histologic type, n (%) | |||
Serous, high-grade | 2 (6) | 6 (13) | |
Serous, low-grade | 1 (3) | 2 (4) | |
Mucinous | 18 (50) | 12 (26) | |
Endometrioid | 10 (28) | 12 (26) | |
Grade 1 | 6 | 4 | |
Grade 2 | 2 | 3 | |
Grade 3 | 1 | 3 | |
Clear cell | 3 (8) | 13 (28) | |
Other a | 2 (6) | 2 (4) | |
Surgical mode,b n (%) | 27 (75) | 41 (87) | 0.241 |
Open | 6 (17) | 3 (6) | |
Laparoscopy Robot | 3 (8) | 3 (6) | |
Type of surgery, n (%) | |||
Primary | 17 (47) | 20 (43) | 0.824 |
Re-staging | 19 (53) | 27 (57) | |
Type of staging procedure, n (%) | |||
Cytology | 33 (92) | 39 (83) | |
Peritoneal biopsies | 30 (83) | 39 (83) | |
Oment biopsy | 31 (86) | 45 (96) | |
LN pelvic | 8 (22) | 24 (51) | |
LN paraaortic | 8 (22) | 22 (47) | |
Adjuvant chemotherapy, n (%) | 14 (39) | 34 (72) | 0.003 |
Histologic review,c n (%) | 33 (92) | 42 (89) | 1.0 |
Recurrence, n (%) | 2 (6) | 6 (13) | |
Died of disease, n (%) | 1 (3) | 2 (4) | |
Follow-up, months, mean (range) | 63 (16–111) | 64 (21–112) | 0.708 |